Observational Study of Meloxicam in Any Labeled Indication

Programa de Experiencia Therapéutica Personalizada (Personalized Therapeutic Experience Program)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02182739

Enrollment

13039

Registered

2014-07-08

Start date

2001-01-31

Completion date

Unknown

Last updated

2014-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Rheumatoid

Brief summary

Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.

Interventions

DRUGMeloxicam

tablets or injectable solution

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients according to the physicians medical criteria on the labeled indications for Meloxicam

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
Change in assessment of intensity of pain on a 4-point verbal rating scale	up to 1 year
Assessment of tolerability on a 4-point scale	up to 1 year

Secondary

Measure	Time frame
Number of patients with adverse events	up to 1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026